telmisartan has been researched along with Diseases, Peripheral Vascular in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhm, M; Foulquier, S; Schmieder, R; Schumacher, H; Sleight, P; Teo, K; Unger, T; Yusuf, S | 1 |
| Liakishev, AA | 1 |
| Chachibaia, ZK; Gerasimenko, ON; Shpagin, IS; Shpagina, LA; Zueva, MA | 1 |
| Giles, TD | 1 |
1 review(s) available for telmisartan and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
A perspective on telmisartan and cardiovascular risk.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Half-Life; Humans; Peripheral Vascular Diseases; Phenotype; Risk Assessment; Risk Factors; Stroke Volume; Telmisartan | 2007 |
3 trial(s) available for telmisartan and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cardiovascular System; Coronary Artery Disease; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Telmisartan; Treatment Outcome | 2014 |
[Telmisartan, ramipril, or both in patients at high risk for vascular events. Results of the ONTARGET trial].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Drug Therapy, Combination; Female; Global Health; Humans; Incidence; Male; Peripheral Vascular Diseases; Ramipril; Risk Factors; Telmisartan; Treatment Outcome | 2008 |
[Remodelling of peripheral vessels in cardiovascular diseases: pathogenesis and treatment with telmisartan].
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Cardiovascular Diseases; Endothelin-1; Endothelium, Vascular; Humans; Male; Middle Aged; Nitric Oxide; Peripheral Vascular Diseases; Telmisartan; Vibration | 2008 |